![](/img/cover-not-exists.png)
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
Fisher, B, Brown, A M, Dimitrov, N V, Poisson, R, Redmond, C, Margolese, R G, Bowman, D, Wolmark, N, Wickerham, D L, Kardinal, C GVolume:
8
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1990.8.9.1483
Date:
September, 1990
File:
PDF, 1001 KB
english, 1990